MedLife’s stock exchange journey in numbers

MedLife became a public company through a high-profile IPO that successfully closed in 2016, and it has continued to deliver growth across the board since then. One year after its listing, the medical services company was included in the reference BET index of the Bucharest Stock Exchange; in 2022, MedLife was included in FTSE Russell's Emerging Markets indices.

The company became the first private medical services operator in Romania to exceed an annual turnover of EUR 400 million. MedLife’s vision is to develop large scale medical hubs in major Romanian cities and offer integrated services, while also investing in digitalization and innovation.

By Ovidiu Posirca

The Medlife Network At A Glance

The company is the largest employer in the local medical sector, with more than 10,000 employees and collaborators, of whom 4,500 are doctors, according to data from December 2022.

• 200 collection centres

• 205 clinics, microclinics, occupational health centres

• 34 medical labs

• 27 hyperclinics

• 23 pharmacies

• 18 dental centres

• 16 hospitals

• 6 COVID labs

• 4 maternity hospitals

• 1 stem cell bank

6 million – the number of unique patients 800,000 – the number of MedLife subscribers 600,000 – the number of investigations processed monthly 30,000 – the daily number of patients using MedLife’s services 98%

– the share of MedLife suppliers who are Romanian

Financial Highlights

Assets rose 4.6 times from 2016 to 2022, reaching RON 2.15 billion

Turnover increased fourfold from 2016 to 2022, reaching RON 2 billion

EBITDA rose 5.2 times from 2016 to 2022, reaching RON 284 million

Yield Performance

Since its IPO, the company’s capitalisation grew 4.65 times, which translates into an yield of 365 percent, outpacing the growth of the BET-TR index, which includes dividends and had a yield of 178.7 percent.

Capital Market Evolution

MedLife is the 13th biggest company on the BVB by market capitalisation, which reached RON 2.4 billion at the end of 2022

MedLife is the seventh most traded company on the BVB

In 2022, MedLife got the maximum score (10/10) for its communication with investors, based on ARIR’s VEKTOR index